Brian K. Halak, 10% Owner at Clovis Oncology, Inc. (CLVS), bought 1,340,875 shares at $13.00 ($12.1M) on 2011-11-21, disclosed to the SEC on 2011-11-21.
Open-market purchase of $12.1M CLVS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 409,192 | $0 | 0.0% |
| 2 | $13.00 | 15,625 | $203K | 1.7% |
| 3 | $13.00 | 916,058 | $11.9M | 98.3% |
| Total | $9.03 avg | 1,340,875 | $12.1M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |